Science Market Update

 

Read More

Tags: Washington University, Washington University St. Louis, WUSTL, Biotechnology vendor show, Bioresearch funding, BioResearch Product Faire, Translational Science, Pediatric Neurology, Birth Defects

Though experts may disagree on when earth’s supply of fossil fuels will be exhausted, they do agree that it will happen eventually. After all, fossil fuels typically require millions of years of degradation to create. So the race for alternative biofuels is on.

The Department of Energy (DOE) recently awarded the Washington University, St. Louis (WUSTL) $3.9 in research funding to develop bacteria that manufactures renewable biofuels. WUSTL scientists are studying Rhodococcus opacus, a bacteria that grows on toxic compounds, using them as a source of food for the production of biofuels. The goal of this research project is to produce biofuels that can completely replace petroleum-based fuels.

Read More

Tags: Washington University, Washington University St. Louis, WUSTL, NIH award, Biotechnology trade show, Biotechnology vendor show, Bioresearch funding, life scinece, life science labs, biofuels, Department of Energy, Renewable Energy, Reproductive Research, laboratory equipment suppliers, BioResearch Product Faire

According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.

Read More

Tags: WUSTL, Washington University St. Louis, Washington University, Research Funding, Biotechnology trade show, biotech vendor show, Bioresearch Grant, WashU, Cancer, Leukemia, Cancer Immunotherapy, Cancer Therapeutics, cancer research, NIH awards 2017, cancer research funding

The Biotechnology Calendar, Inc. BioResearch Product Faire™ will be returning to Washington University, St. Louis for its 19th Annual event.  WashU's Life Science R&D Expenditures and NIH funding has been totaling about $1 Billion the past few years proving the University's dedication to being at the forefront of life science research and providing a prime opportunity for boosting scientific sales.

Read More

Tags: WashU, Washington University, Washington University St. Louis, St Louis, MO, 2018

Washington University in St. Louis has 1 of 57 Institutes of Clinical and Translation Sciences (ICTS) in the United States. The ICTS at Washington University focuses on translating discoveries from both translation and clinical research into new treatments and therapies. The ICTS does not focus on just one area of life science research. Instead, researchers from all spectrums on the health sciences are able to use the institutes resources to further their work on topics like disease prevention and treatment. Training programs are also offered through the institute for researchers. (Image courtesy of P. David via Wikimedia Commons)

Read More

Tags: 2018, BioResearch Product Faire Event, WashU, Washington University St. Louis, MO, NIH funding, Clinical and Translational Research, clinical and translational research funding

The National Institute of Health (NIH) awarded Washington University in St. Louis over $1.4 million in grant funding to support their School of Medicine’s Diabetic Research Center. This award was administered through the National Institute of Diabetes and Digestive and Kidney Diseases  (NIDDK) as it has been for the last 38 years. The funding will help support the Diabetic Research Center (DRC) and their life science labs. The DRC's mission is to “support and enhance research in diabetes and related metabolic diseases” through Biomedical Research Core services as well as the Pilot and Feasibility Program.

Read More

Tags: Washington University, Washington University St. Louis, WUSTL, NIH award, Biotechnology trade show, Biotechnology vendor show, Diabetes, Bioresearch funding, life scinece, life science labs

Washington University School of Medicine in St. Louis is leading an international team studying potential treatments to prevent Alzheimer’s disease. The team recently added a third medicationin this worldwide clinical trial that is already underway. According to the WU School of Medicine news site, the latest investigational drug “is designed to lower production of amyloid beta, a protein that clumps together into plaques damaging neurons in the brain, leading to memory loss, cognitive problems and confusion.”

Read More

Tags: WUSTL, Washington University St. Louis, Washington University, Alzheimer' Research, Alzheimer’s, Alzheimer's treatment market, Research Funding, Biotechnology trade show, biotech vendor show, Bioresearch Grant

Despite recent advances in neuroimaging, the medical community still lacks a comprehensive map of the brain and how it changes with age. Such maps would make it possible for doctors to distinguish between what is normal aging and what is atypical, which would make it possible to link atypical changes to neurological diseases and various mental health issues. Thanks to a $34 million NIH grant, Washington University School of Medicine in St. Louis will lead a project to make such maps of the brain a reality.

Read More

Tags: WUSTL, Washington University St. Louis, Research Funding, research grants, NIH grant, Biotechnology Vendor Fair, laboratory equipment sales

A team of researchers led by Gaya Amarasinghe, associate professor of Pathology and Immunology at Washington University School of Medicine, was recently awarded a $13 million NIH grant to study the replication process of the Ebola virus. 

Read More

Tags: Washington University St. Louis, Midwest Region, MO, Research Funding, NIH grant, ebola

The National Institutes of Health (NIH) recently launched a new network of institutions - called the Centers for Common Disease Genomics (CCDG) - which will study common conditions such as heart disease, stroke, diabetes, and autism to see how genetics and DNA contribute to the risk of these diseases. The McDonnell Genome Institute at Washington University in St. Louis is one of four institutions involved in this network and will be receiving $60 million over the next four years to study genomics and common diseases.    

Read More

Tags: Washington University St. Louis, Midwest, Missouri, WashU, heart disease, Diabetes, Autism, BioResearch Product Faire Event, MO, St Louis, NIH funding, 2016, Centers for Common Disease Genomics, stroke, CCDG